Pascal Touchon

President and Chief Executive Officer • Atara Biotherapeutics

With more than 30 years of global biopharmaceutical leadership experience, Pascal Touchon joined Atara Biotherapeutics as President, Chief Executive Officer and member of the Board of Directors in June 2019. Pascal has committed his career to transforming the lives of patients with serious medical conditions through pioneering science, teamwork, and a commitment to excellence.

Previously Global Head, Cell & Gene and member of the Oncology Executive Committee at Novartis Oncology, he oversaw the Oncology Cell & Gene unit and had responsibility for the unit’s financial performance and its activities, including the global launch of KYMRIAH® (tisagenlecleucel), securing regulatory approval and reimbursement in major markets, expanding global CAR T manufacturing and technical operations, overseeing multiple new clinical studies, and building a strong leadership team.

Also Speaking

Tamer Mohamed

President & Chief Executive Officer • Aspect Biosystems

Timothy Schroeder

Chairman, Chief Executive Officer and Founder • CTI

Nina Bauer

Senior Director, Head of Commercial, Gene Therapy • MilliporeSigma

Event Info


Fun Run